Abstract
The concept of using radiolabeled antibodies capable of localizing the hidden cancer cells [14] has been revitalized by the discovery of the monoclonal antibody (Mab) technology [9]. This discovery has not yet led to the identification of absolutely specific tumor antigens, but has allowed the selection of perfectly homogeneous Mabs which bind with high affinity to tumor-associated markers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach J-P (1983) Radio-labeled fragments of monoclonal anti-CEA antibodies for localization of human colon carcinoma grafted into nude mice. J Exp Med 158: 413–427
Buchegger F, Schreyer M, Carrel S, Mach J-P (1984) Monoclonal antibody identify a CEA cross-reacting antigen of 95 KD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 KD. Int J Cancer 33: 643–649
Burtin P, Quan PC, Sabine MC (1975) Nonspecific cross-reacting antigen as a marker for human polymorphs, macrophages and monocytes. Nature 255: 714
Delaloye B, Bischof-Delaloye A, Buchegger F, von Fliedner V, Grob FR, Volant J-C, Pettavel J, Mach J-P (1986) Detection of Colorectal Carcinom by Emission-computerized Tomography after injection of 123I-labeled Fab or F(ab’)2 Fragments from Monoclonal Anti-Carcinoembryonic Antigen Antibodies. J Clin Invest Vol.77, January 1986 (in press)
Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121: 439
Granowska M, Shepherd J, Britton KE, Ward B, Mather S, Taylor-Papadimitriou J, Epenetos AA, Carroll MJ, Nimmon CC, Hawkins LA, Slevin M, Flatman W, Horne T, Burchell J, Durbin H, Bodmer W (1984) Ovarian cancer: diagnosis using 1231 monoclonal antibody in comparison with surgical findings. Nuclear Med Commun 5: 485–499
Hammersmith Oncology Group and Imperial Cancer Research Fund (1983) Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. Lancet I: 1441–1443
Haskell CM, Buchegger F, Schreyer M, Carrel S, Mach J-P (1983) Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Cancer Res 43: 3857–3864
Köhler G, Milstein C (1975) Continous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 455–457
Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham MM, Hill LD, Beaumier PL, Hellström KE, Hellström I (1983) Localization of 131-I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72: 2101–2114
Leichner PK, Klein JL, Siegelman SS, Ettinger DS, Order SE (1983) Dosimetry of I-131 labeled anti-ferritin in hepatoma: specific activities in the tumor and liver. Cancer Treat Rep 67: 647–6518
Mach J-P, Pustaszeri G (1972) Carcinoembryonic antigen (CEA): demonstration of partial identity between CEA and a normal glycoprotein. Immunochemistry 9: 10–31
Mach J-P, Carrel S, Merenda C, Sordat B, Cerottini J-C (1974) In vivo localisation of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248: 704–706
Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso JD, Schreyer M, Girardet Ch, Accolla RS, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2: 239–249
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Grob, JP. et al. (1986). Cancer Detection by Immunoscintigraphy, Selection, and Clinical Application of Monoclonal Anti-CEA Antibodies and Their F (ab′)2 or Fab Fragments. In: Herfarth, C., Schlag, P., Hohenberger, P. (eds) Therapeutic Strategies in Primary and Metastatic Liver Cancer. Recent Results in Cancer Research, vol 100. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82635-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-82635-1_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82637-5
Online ISBN: 978-3-642-82635-1
eBook Packages: Springer Book Archive